These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2113469)

  • 1. Long-term parenteral nutrition and metabolic bone disease.
    Hurley DL; McMahon MM
    Endocrinol Metab Clin North Am; 1990 Mar; 19(1):113-31. PubMed ID: 2113469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aluminum as a factor in the bone disease of long-term parenteral nutrition.
    Klein GL; Ott SM; Alfrey AC; Sherrard DJ; Hazlet TK; Miller NL; Maloney NA; Berquist WE; Ament ME; Coburn JW
    Trans Assoc Am Physicians; 1982; 95():155-64. PubMed ID: 6820740
    [No Abstract]   [Full Text] [Related]  

  • 3. Complications of parenteral nutrition.
    Ukleja A; Romano MM
    Gastroenterol Clin North Am; 2007 Mar; 36(1):23-46, v. PubMed ID: 17472873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic bone disease in home total parenteral nutrition.
    McCullough ML; Hsu N
    J Am Diet Assoc; 1987 Jul; 87(7):915-20. PubMed ID: 3110249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ESPEN Guidelines on Parenteral Nutrition: home parenteral nutrition (HPN) in adult patients.
    Staun M; Pironi L; Bozzetti F; Baxter J; Forbes A; Joly F; Jeppesen P; Moreno J; Hébuterne X; Pertkiewicz M; Mühlebach S; Shenkin A; Van Gossum A;
    Clin Nutr; 2009 Aug; 28(4):467-79. PubMed ID: 19464089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multifactorial low remodeling bone disease during cyclic total parenteral nutrition.
    de Vernejoul MC; Messing B; Modrowski D; Bielakoff J; Buisine A; Miravet L
    J Clin Endocrinol Metab; 1985 Jan; 60(1):109-13. PubMed ID: 3917265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Calcitonin treatment of metabolic bone disease induced by parenteral nutrition].
    Wasmuth HH; Verhage CC
    Tidsskr Nor Laegeforen; 1993 Jun; 113(16):1987-9. PubMed ID: 8322348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gallbladder disease in patients on long-term parenteral nutrition.
    Roslyn JJ; Pitt HA; Mann LL; Ament ME; DenBesten L
    Gastroenterology; 1983 Jan; 84(1):148-54. PubMed ID: 6401182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma Aluminum Concentrations in Pediatric Patients Receiving Long-Term Parenteral Nutrition.
    Courtney-Martin G; Kosar C; Campbell A; Avitzur Y; Wales PW; Steinberg K; Harrison D; Chambers K
    JPEN J Parenter Enteral Nutr; 2015 Jul; 39(5):578-85. PubMed ID: 24743391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aluminum exposure from parenteral nutrition in preterm infants: bone health at 15-year follow-up.
    Fewtrell MS; Bishop NJ; Edmonds CJ; Isaacs EB; Lucas A
    Pediatrics; 2009 Nov; 124(5):1372-9. PubMed ID: 19858156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ESPEN Guidelines on Parenteral Nutrition: non-surgical oncology.
    Bozzetti F; Arends J; Lundholm K; Micklewright A; Zurcher G; Muscaritoli M;
    Clin Nutr; 2009 Aug; 28(4):445-54. PubMed ID: 19477052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of the relationship between parenteral nutrition and metabolic bone disease.
    Ferrone M; Geraci M
    Nutr Clin Pract; 2007 Jun; 22(3):329-39. PubMed ID: 17507733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selenium deficiency and fatal cardiomyopathy in a patient receiving long-term home parenteral nutrition.
    Quercia RA; Korn S; O'Neill D; Dougherty JE; Ludwig M; Schweizer R; Sigman R
    Clin Pharm; 1984; 3(5):531-5. PubMed ID: 6435941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic bone disease associated with total parenteral nutrition.
    Klein GL; Coburn JW
    Adv Nutr Res; 1984; 6():67-92. PubMed ID: 6439013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D-lactate and metabolic bone disease in patients receiving long-term parenteral nutrition.
    Karton MA; Rettmer R; Lipkin EW; Ott SM; Chait A
    JPEN J Parenter Enteral Nutr; 1989; 13(2):132-5. PubMed ID: 2496243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic bone disease in patients receiving long-term total parenteral nutrition.
    Shike M; Harrison JE; Sturtridge WC; Tam CS; Bobechko PE; Jones G; Murray TM; Jeejeebhoy KN
    Ann Intern Med; 1980 Mar; 92(3):343-50. PubMed ID: 6766694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aluminum is associated with low bone formation in patients receiving chronic parenteral nutrition.
    Ott SM; Maloney NA; Klein GL; Alfrey AC; Ament ME; Coburn JW; Sherrard DJ
    Ann Intern Med; 1983 Jun; 98(6):910-4. PubMed ID: 6407375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Total parenteral nutrition and its effects on bone metabolism.
    Klein GL; Coburn JW
    Crit Rev Clin Lab Sci; 1994; 31(2):135-67. PubMed ID: 7917007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic bone diseases during long-term total parenteral nutrition.
    Acca M; Ragno A; Francucci CM; D'Erasmo E
    J Endocrinol Invest; 2007; 30(6 Suppl):54-9. PubMed ID: 17721075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.